[Identification of serum alkaline phosphatase from human bone]

Area of Science:

• Biochemistry
• Molecular Biology
• Clinical Chemistry

Context:

• Osteosarcoma, fibrous dysplasia, and metastatic bone tumors are skeletal disorders associated with altered alkaline phosphatase levels.
• Idiopathic hyper-alkalinephosphatasemia presents a unique challenge in diagnosing bone-related conditions.
• Characterizing serum alkaline phosphatase is crucial for differential diagnosis and understanding bone metabolism.

Purpose:

• To characterize the biochemical properties of serum alkaline phosphatase in patients with various skeletal disorders.
• To identify commonalities in alkaline phosphatase activity across different bone conditions.
• To investigate the inhibition, thermal stability, and substrate specificity of serum alkaline phosphatase.

Summary:

• Polyacrylamide gel electrophoresis revealed a uniform molecular weight of 60,000 for alkaline phosphatase in sera from patients with osteosarcoma, fibrous dysplasia, metastatic bone tumor, and idiopathic hyper-alkalinephosphatasemia.
• Alkaline phosphatase activity was more strongly inhibited by L-homoarginine than L-phenylalanine and was inactivated by heating.
• Substrate specificity studies indicated differential hydrolysis rates for various phosphate compounds, with higher rates for alpha- and beta-glycerophosphate compared to phenylphosphate.

Impact:

• The study identifies shared characteristics of serum alkaline phosphatase in patients with skeletal disorders, potentially improving diagnostic markers.
• Understanding these biochemical properties can aid in differentiating various bone conditions.
• This research contributes to the fundamental knowledge of alkaline phosphatase in the context of bone diseases.